Taiwan FDA registration fa7a7d06d61a1f62b9a6105914108dbb
Beipu uses insulin injections at a single time
TW: 貝普一次性使用胰島素針
Taiwan·Risk Class 2·Berpu Medical Technology Co., Ltd.·Registered Jan 30, 2016 – Jan 30, 2026ExpiredRegistration details
- Analysis ID
- fa7a7d06d61a1f62b9a6105914108dbb
- Customs Code
- DHA09200072807
Company information
- Manufacturer
- Berpu Medical Technology Co., Ltd.
- Manufacturer Country
- China
- Authorized Representative
- JIAMEI MEDICAL INTERNATIONAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5570 Subcutaneous single-chamber needle
- Import Information
- Chinese goods;; input
Dates and status
- Registration Date
- Jan 30, 2016
- Expiry Date
- Jan 30, 2026
About this record
Access comprehensive regulatory information for Beipu uses insulin injections at a single time in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fa7a7d06d61a1f62b9a6105914108dbb and manufactured by Berpu Medical Technology Co., Ltd.. The authorized representative in Taiwan is JIAMEI MEDICAL INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices